Healthcare
Live Price
Offline$29.63
+4.29% today
1Y Change
+264.92%
Window
Jun 20, 2025 → May 29, 2026
Coverage: 237 bars · Jun 20, 2025 → May 29, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Sutro Biopharma, Inc. (STRO) is a Healthcare stock with a market cap of $300.00M and listed on NASDAQ. The stock last traded around $29.63 and up 264.9% across the available one-year price window (Jun 20, 2025 → May 29, 2026). Baseline metrics include revenue growth of +65.2%, EPS growth of +24.0%, a dividend yield of 0.0%. What stands out right now is revenue +65.2%, EPS +24.0%, free cash flow +8.1% with operating margin -150.2% and ROIC -144.5%. Valuation is more restrained than many high-expectation growth names at price/sales 3.0. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines STRO price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
STRO
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
STRO Max Drawdown
-39.17%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for STRO and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.